Evidence map›Paper›PMID 23346981›Full record

ReviewCritical reviews in toxicology2013

The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Scott M Arnold, Juergen Angerer, Peter J Boogaard, Michael F Hughes, Raegan B O'Lone, Steven H Robison, A Robert Schnatter

Open access · bronzeAbstract readReview
In one paragraph

Review in Critical reviews in toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Exposures from Oil and Gas Development and Childhood Leukemia Risk in Colorado: A Population-Based Case-Control Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Smoke exposure associated with higher urinary benzene biomarker muconic acid (MUCA) in Golestan Cohort Study participants.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2023
    Article
  14. Review
  15. Influence of Environmental Exposure to Steel Waste on Endocrine Dysregulation andInternational journal of environmental research and public health · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. Handheld Device for Selective Benzene Sensing over Toluene and Xylene.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 4 countries.

Scott M ArnoldThe Dow Chemical Company, Midland, MI 48674, USA. smarnold@dow.com
Juergen Angerer
Peter J Boogaard
Michael F Hughes
Raegan B O'Lone
Steven H Robison
A Robert Schnatter
Dow Chemical (United States) · USEnvironmental Protection Agency · USExxonMobil (United States) · USHealth and Environmental Sciences Institute · USInstitut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung · DEProcter & Gamble (United States) · USShell (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract A framework of "Common Criteria" (i.e. a series of questions) has been developed to inform the use and evaluation of biomonitoring data in the context of human exposure and risk assessment. The data-rich chemical benzene was selected for use in a case study to assess whether refinement of the Common Criteria framework was necessary, and to gain additional perspective on approaches for integrating biomonitoring data into a risk-based context. The available data for benzene satisfied most of the Common Criteria and allowed for a risk-based evaluation of the benzene biomonitoring data. In general, biomarker (blood benzene, urinary benzene and urinary S-phenylmercapturic acid) central tendency (i.e. mean, median and geometric mean) concentrations for non-smokers are at or below the predicted blood or urine concentrations that would correspond to exposure at the US Environmental Protection Agency reference concentration (30 µg/m(3)), but greater than blood or urine concentrations relating to the air concentration at the 1 × 10(-5) excess cancer risk (2.9 µg/m(3)). Smokers clearly have higher levels of benzene exposure, and biomarker levels of benzene for non-smokers are generally consistent with ambient air monitoring results. While some biomarkers of benzene are specific indicators of exposure, the interpretation of benzene biomonitoring levels in a health-risk context are complicated by issues associated with short half-lives and gaps in knowledge regarding the relationship between the biomarkers and subsequent toxic effects.

Indexed as

AnimalsBenzeneBiomarkersCarcinogens, EnvironmentalDrug SynergismEnvironmental ExposureEnvironmental MonitoringHumansInhalation ExposureNeoplasmsReference ValuesRisk AssessmentSmokingToxicity TestsBenzeneBiomarkersCarcinogens, Environmental

Identifiers

PMID23346981
PMCPMC3585443
OpenAlexW2066529159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.